Drugs & Targets FDA approves Genentech’s Hemlibra to prevent bleeding in hemophilia A November 17, 2017Vol.43 No.43
In Brief De la Chapelle receives lifetime achievement award from colorectal cancer group November 17, 2017Vol.43 No.43
In Brief Gallagher named vice president and head of Global Oncology Development at AbbVie November 17, 2017Vol.43 No.43
In Brief WPI’s Mattson receives $1.7-million NIH award to develop molecular methods November 17, 2017Vol.43 No.43
In Brief LUNGevity partners with ALK Positive Patient Group to fund research November 17, 2017Vol.43 No.43
Caligiuri resigns as CEO of the James after stepping down as director of OSUCCC November 17, 2017Vol.43 No.43By Matthew Bin Han Ong
Defining the next level for InovaSecond story in a three-part series November 17, 2017Vol.43 No.43By Paul Goldberg
Drugs & Targets FDA has accepts Genentech’s BLA for a subcutaneous formulation of rituximab in blood cancer indications November 11, 2017Vol.42 No.42
